Literature DB >> 1582327

Lung disease associated with orally administered mesalamine for ulcerative colitis.

M A Reinoso1, K W Schroeder, R J Pisani.   

Abstract

Pulmonary symptoms, bilateral interstitial infiltrates and gas exchange abnormalities developed in a patient with ulcerative colitis treated with orally administered mesalamine. Improvement of symptoms and objective findings occurred after drug discontinuation. To the best of our knowledge, this is the first report of lung toxicity associated with orally administered mesalamine.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1582327     DOI： 10.1378/chest.101.5.1469

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  11 in total

1.  Is mesalamine safe?

Authors:  Kenneth W Schroeder
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-11

2.  Mesalamine-induced Pneumonitis and Serum Sickness-like Reaction.

Authors:  Adam Harris; Shanti Eswaran; Brian Bosworth; Maya Gambarin-Gelwan; Ellen J Scherl
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-11

3.  Asymptomatic presentation of mesalamine-induced lung injury in an adolescent with Crohn disease.

Authors:  Rafael Cilloniz; Sarah Elizabeth Chesrown; Regino P Gonzalez-Peralta
Journal:  BMJ Case Rep       Date:  2009-03-20

4.  Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity.

Authors:  José Ferrusquía; Isabel Pérez-Martínez; Ricardo Gómez de la Torre; María Luisa Fernández-Almira; Ruth de Francisco; Luis Rodrigo; Sabino Riestra
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

5.  Mesalazine toxicity.

Authors:  D Honeybourne
Journal:  BMJ       Date:  1994-02-19

Review 6.  Comparative tolerability of treatments for inflammatory bowel disease.

Authors:  R B Stein; S B Hanauer
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

Review 7.  Pulmonary involvement and allergic disorders in inflammatory bowel disease.

Authors:  Nikolaos E Tzanakis; Ioanna G Tsiligianni; Nikolaos M Siafakas
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

8.  Acute respiratory failure secondary to mesalamine-induced interstitial pneumonitis.

Authors:  Albin Abraham; Ali Karakurum
Journal:  BMJ Case Rep       Date:  2013-08-20

9.  Mesalazine-induced lung fibrosis.

Authors:  Ebraheem Alskaf; Amer Aljoudeh; Frank Edenborough
Journal:  BMJ Case Rep       Date:  2013-04-09

10.  Eosinophilic Pneumonia in a Patient with Ulcerative Colitis.

Authors:  Keyur B Patel; Matthew M Robbins; Mitchell L Simon; Judith K Amorosa
Journal:  Radiol Case Rep       Date:  2015-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.